(E)-1-((hydroxyimino)(4-methoxyphenyl)methyl)-5-iodopyrimidine-2,4(1H,3H)-dione

ID: ALA4294814

PubChem CID: 145993844

Max Phase: Preclinical

Molecular Formula: C12H10IN3O4

Molecular Weight: 387.13

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc(/C(=N\O)n2cc(I)c(=O)[nH]c2=O)cc1

Standard InChI:  InChI=1S/C12H10IN3O4/c1-20-8-4-2-7(3-5-8)10(15-19)16-6-9(13)11(17)14-12(16)18/h2-6,19H,1H3,(H,14,17,18)/b15-10+

Standard InChI Key:  JRAMKTLSJNBXLL-XNTDXEJSSA-N

Molfile:  

     RDKit          2D

 20 21  0  0  0  0  0  0  0  0999 V2000
    7.2597   -7.1481    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5495   -6.7362    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.5495   -5.9167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2597   -5.5090    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9700   -5.9167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9700   -6.7362    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.2597   -7.9676    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.8392   -5.5090    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.2597   -4.6894    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0
    8.6803   -7.1481    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3906   -6.7362    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3906   -5.9167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8071   -5.9167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0968   -7.1481    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0968   -5.5090    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8071   -6.7362    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6803   -7.9676    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.3906   -8.3753    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.5210   -5.5033    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.2360   -5.9149    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  1  6  1  0
  1  7  2  0
  3  8  2  0
  4  9  1  0
 11 12  1  0
 11 14  2  0
 12 15  2  0
 13 15  1  0
 13 16  2  0
 14 16  1  0
 10 11  1  0
 17 18  1  0
 10 17  2  0
  6 10  1  0
 13 19  1  0
 19 20  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4294814

    ---

Associated Targets(Human)

TYMP Tclin Thymidine phosphorylase (504 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 387.13Molecular Weight (Monoisotopic): 386.9716AlogP: 0.83#Rotatable Bonds: 2
Polar Surface Area: 96.68Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 7.06CX Basic pKa: CX LogP: 1.82CX LogD: 1.32
Aromatic Rings: 2Heavy Atoms: 20QED Weighted: 0.26Np Likeness Score: -0.59

References

1. Zhao S, Li K, Jin Y, Lin J..  (2018)  Synthesis and biological evaluation of novel 1-(aryl-aldehyde-oxime)uracil derivatives as a new class of thymidine phosphorylase inhibitors.,  144  [PMID:29247859] [10.1016/j.ejmech.2017.12.016]

Source